New Key Statistics Module, Z-Score and F-Score
LSE:GSK Key Ratios
| Market Cap £ M | 64,702.80 |
| Enterprise Value £ M | 77,728.80 |
| P/E(ttm) | 14.09 |
| PE Ratio without NRI | 12.86 |
| Forward PE Ratio | 10.08 |
| Price/Book | 4.81 |
| Price/Sales | 2.25 |
| Price/Free Cash Flow | 15.27 |
| Price/Owner Earnings | 11.44 |
| Payout Ratio % | 0.45 |
| Revenue (TTM) £ M | 30,328.00 |
| EPS (TTM) £ | 1.12 |
| Beneish M-Score | -2.6 |
| 10-y EBITDA Growth Rate % | 1.10 |
| 5-y EBITDA Growth Rate % | 1.00 |
| y-y EBITDA Growth Rate % | 4.90 |
| EV-to-EBIT | 11.45 |
| EV-to-EBITDA | 8.56 |
| PEG | 12.86 |
| Shares Outstanding M | 4,144.88 |
| Net Margin (%) | 16.25 |
| Operating Margin % | 24.22 |
| Pre-tax Margin (%) | 20.00 |
| Quick Ratio | 0.62 |
| Current Ratio | 0.88 |
| ROA % (ttm) | 8.27 |
| ROE % (ttm) | 40.01 |
| ROIC % (ttm) | 12.70 |
| Dividend Yield % | 3.66 |
| Altman Z-Score | 1.86 |
| Piotroski F-Score | 5.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | N |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | N |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | Y |
| Higher Asset Turnover y-y | Y |
LSE:GSK Number of Guru Trades
LSE:GSK Volume of Guru Trades
Gurus Latest Trades with LSE:GSK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
LSE:GSK is held by these investors
Total 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers